Zhejiang Medicine Co Ltd (600216) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceuticals products in China and internationally. The company offers synthetic vitamin E, vitamin A, natural vitamin E, ß-carotene, canthaxanthin, vancomycin hydrochloride, teicoplanin, and daptomycin.

Total Assets Chart for Zhejiang Medicine Co Ltd

Zhejiang Medicine Co Ltd (600216) total assets for FY2025 were CNY 14.1B, a 2.1% change from FY2024. Zhejiang Medicine Co Ltd's total assets grew from CNY 946.4M in 1997 to CNY 14.1B in 2025 (1388.9% over 28 years). Total assets compound annual growth rate: 5-year CAGR of 6.1%, 10-year CAGR of 5.5%, 20-year CAGR of 9.7%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (CNY)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
¥12.13B
Implied Share Price
¥12.61
Enterprise Value
¥9.14B
Revenue (TTM)
¥8.94B
EBITDA
¥1.52B
Profit Margin
9.01%
Trailing P/E
15.01
Forward P/E
13.39
Price/Book (MRQ)
1.05
Price/Sales (TTM)
1.36
EV/EBITDA
5.71
EV/Revenue
1.02
Dividend Yield
2.20%
Book Value
¥12.30
Free Cash Flow (FY2025)
¥1.44B
Free Cash Flow Yield
11.87%

Snapshot as of 23rd September 2026 — not point-in-time controlled, may lag the live market by a few days.